Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget. 6:6295-6309.